SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors respond to a series of high-impact legal and commercial catalysts, including a transformative patent settlement with Samsung and an ongoing ITC patent infringement case against Micron. The community is actively discussing the stock's potential for a short squeeze and long-term revaluation, with many shareholders focused on the company's essential role in AI-driven memory infrastructure.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as market participants weigh strong AI-driven memory demand against technical volatility and ongoing patent litigation debates. The community is actively discussing the stock's potential for further gains as a crucial supplier for AI infrastructure, while debating the long-term impact of regulatory pressures and bearish short interest positions.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors actively fuel a short squeeze, pushing the stock toward recent highs while mocking high-profile short sellers who doubled down on bearish bets. The community is sharply divided between bulls celebrating rapid growth in AI-cloud infrastructure demand and skeptics pointing to high valuation multiples and ongoing permitting challenges at data center sites.

Roundhill ETF Trust - Roundhill Memory ETF

The DRAM ETF is experiencing a significant surge as investors rotate back into semiconductor stocks, fueled by strong earnings sentiment in the memory sector and a recovery in South Korean chipmakers. Market participants are actively discussing the potential for a sustained rally as structural AI-driven demand continues to outweigh short-term volatility concerns.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending following a successful Investor Day where management highlighted multi-year supply contracts and robust margin targets, leading to multiple analyst upgrades. The community is sharply divided, with bulls pointing to these long-term institutional commitments as evidence of a structural AI memory supercycle, while bears caution against cyclical volatility and potential demand pullbacks in the broader AI infrastructure sector.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a significant regulatory pivot, as the FDA has signaled a willingness to review a major BLA amendment focusing on the primary skeletal muscle endpoint rather than the previously rejected cardiac indication. While the community is actively debating the strength of this path forward and the potential for a short squeeze given high institutional interest and borrow fees, many retail traders remain focused on the potential for an upcoming PDUFA extension to provide a runway for approval.

Aventus Network

Aventus Network is seeing heightened activity and community discourse surrounding extreme price volatility and technical issues with major exchanges. While some participants are navigating the sharp swings as a potential opportunity, others are debating the project's long-term utility in the enterprise blockchain sector.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is trending amidst a broader market rally driven by optimism surrounding potential diplomatic progress in the Middle East and cooling inflation fears. The community is actively debating the sustainability of current valuations, with many users focused on the influence of AI capital expenditure and conflicting institutional viewpoints on the market's long-term trajectory.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining significant momentum as investors digest recent clinical progress and prepare for a pivotal BLA filing by the end of the year. The community is actively discussing the company's strong institutional backing and the transformative potential of their immunotherapy platform in localized prostate cancer and NSCLC.

Anthropic

Anthropic is trending as it prepares for a high-profile IPO, with investors closely watching its record-breaking revenue surge and competitive race against OpenAI. The community is actively debating the company's massive valuation, potential infrastructure deals, and the implications of its frontier AI models on cybersecurity and industry competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

11 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million.
Liminatus Pharma (NASDAQ:LIMN)read more...

ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition

Alkermes inks $2.1B deal to acquire Avadel, adding the latter's Lumryz and new growth potential to its portfolio.

Best Momentum Stocks to Buy for Oct. 23

PARR, CMMB and GES made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 23, 2025.

New Strong Buy Stocks for Oct. 23: MQ, GES and More

MQ, GES, TRV, CMMB and PARR have been added to the Zacks Rank #1 (Strong Buy) List on Oct. 23, 2025.

SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study

Sanofi's efdoralprin alfa meets all key endpoints in a global phase II study, showing potential as a first restorative recombinant therapy for AATD.

Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis

RHHBY secures FDA approval to expand Gazyva's label for treating lupus nephritis, offering patients a faster and more convenient treatment option.

NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients

Novo Nordisk secures FDA approval for Rybelsus as the first oral GLP-1 therapy proven to cut major heart risks in adults with type II diabetes.

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

Esperion selects ESP-2001 as a preclinical candidate for primary sclerosing cholangitis, a rare liver disease, aiming to begin clinical studies in 2026.

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs 

Trump's pledge to slash GLP-1 drug prices sends Novo Nordisk and Eli Lilly shares tumbling, raising questions about the feasibility of such a development.

Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan

VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan, gaining rights to pitolisant and Spydia for narcolepsy and seizure management, respectively.

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

Chemomab Therapeutics Ltd - ADR

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.91
Prev Close	$1.90
Open	$1.92
Dividend Yield	0.00%
50-Day Moving Average	$1.70
Beta	1.03
Avg. Volume	282,422.59
PE Ratio	-1.72

52-Week High	$4.12
52-Week Low	$1.35
Market Capitalization	$13.75M
EPS (Annual)	-$1.42
Price to Book	1.29
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info